Nav: Home

Study pinpoints opportunity for oncologists to improve prognosis communication

January 24, 2017

An accurate prognosis for a patient with incurable cancer can help a family make important end-of-life decisions. However, previous research shows that many (or even most) patients with advanced cancer misunderstand their prognosis. A study published in the Journal of Oncology Practice explored doctor-patient conversations at four major academic medical centers to show that patients and their doctors naturally avoid difficult discussions about a challenging prognosis. The paper also pinpoints an opportunity to create a space for this discussion to take place. After communicating test results, an oncologist who asks, "Would you like to talk about what this means?" prompts patients to consider how much they want to know and gives them permission to explore a serious discussion about life and death.

"It was surprising -- at all four of these medical centers, the conversations that oncologists had with their patients tended to follow the same pattern. They would discuss symptoms, then the oncologist would reveal scan results often followed by an immediate transition to talking about the next steps for treatment. What's often missing is a discussion of what the scan results mean," says Sarguni Singh, MD, oncology hospitalist at the University of Colorado Cancer Center. Singh performed her study during residency at the University of Wisconsin with mentor Toby C. Campbell, MD.

The study analyzed 64 conversations recorded as part of a large, multi-site cancer clinical trial. In these conversations, when the oncologist communicated bad news, an average of 50 percent of the conversation was occupied by talk about treatment options. Only 10 percent of all conversations were about scan results. And in these 64 conversations, there were only four instances in which oncologists directly discussed prognosis with their patients.

"The oncologist doesn't want to give a negative view and the patient doesn't want to hear it. They collude to avoid this elephant in the room," Singh says, pointing out that in no way is this collusion intentional. Rather, avoiding the topic of patient's poor prognosis is a cultural norm that, unless consciously countered, can steer doctor-patient communication away from end-of-life topics.

Singh points out that often family members or caregivers are present with a patient and that while it has been shown that patients may misinterpret even frank discussions of prognosis, "the caregivers are processing it too, and maybe in a more intellectual way than the patient," Singh says.

Appreciating a difficult prognosis could allow patients to avoid treatments destined to result in little gain, high cost, and significant side effects.

"Most importantly, these prognosis conversations aren't happening. If it does, it happens very quickly. And patients aren't processing the news," Singh says.

By pausing to ask if a patient wants to talk about what the test results mean, an oncologist can create the opportunity for a patient and his or her family to give their permission to look beyond the "can-do" next steps of treatment to a more holistic understanding of their situation. Dr. Singh and her colleagues think this simple question could open up a dialogue between patients and their oncologists that currently does not exist.

University of Colorado Anschutz Medical Campus

Related Oncologists Articles:

Tailor-made for older adults, new tools improve doctor-patient relations
A Wilmot Cancer Institute-led study in JAMA Oncology shows that when physicians fully appreciate the concerns of older adults with cancer, such as function and forgetfulness, it elevates patient care and satisfaction.
One in four oncologists fails to mention cost when discussing genomic testing
Nearly one in four oncologists discussing genomic testing with their patients rarely or never discusses the costs of testing, according to a new study led by American Cancer Society investigators.
Oncologists respond swiftly to FDA safety alerts, Penn study finds
Within six months of the U.S. Food and Drug Administration's (FDA) move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
Oncologists echo findings that suggest a reduced risk of breast cancer recurrence
Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast cancer.
ASCO: Oncologists see benefit of medical marijuana, but not comfortable prescribing
73 percent of oncology providers believe that medical marijuana provides benefits for cancer patients, but only 46 percent are comfortable recommending it.
Survey questions cancer doctors' awareness of LGBTQ issues
Most oncologists say they don't know enough about how to treat patients with differences in sexual orientation or identity, but most are also interested in learning more, a new study finds.
Moffitt leads the nation in addressing LGBTQ health care disparities and education
Moffitt launched the first nationwide survey to identify potential gaps in attitudes, knowledge and institutional practices for LGBTQ patients.
Oncologists' LGBT-related knowledge & practices improved after cultural competency training
An interactive online LGBT cultural competency training program for oncologists may be acceptable, feasible, and improve LGBT-related knowledge and clinical practices.
Oncologists demand more education on the use of biosimilars: ESMO takes action
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines -- but they are also expensive.
Curing breast cancer but at what cost? Patients report heavy financial toll
A new study led by researchers at the University of Michigan Rogel Cancer Center finds many breast cancer patients are concerned about the financial impact of their diagnosis and treatment, and that they feel their doctor's offices are not helping with these concerns.
More Oncologists News and Oncologists Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at